Formula Growth LTD Pulmonx Corp Transaction History

Formula Growth LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$15.35 - $23.99 $535,975 - $837,658	-34,917 Reduced 63.54%	20,034 $334,000
Q1 2022 May 13, 2022	SELL	$21.13 - $35.65 $78,666 - $132,724	-3,723 Reduced 6.35%	54,951 $1.36 Million
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $39,408 - $59,802	-1,326 Reduced 2.21%	58,674 $1.88 Million
Q3 2021 Nov 12, 2021	BUY	$35.98 - $44.48 $2.16 Million - $2.67 Million	60,000 New	60,000 $2.16 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

Stay updated on Formula Growth LTD with notifications on news.